SBI Securities
ATRC icon

SBI Securities’s AtriCure ATRC Stock Holding History

SBI Securities’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.87K Buy
+51
New +$2.3K ﹤0.01% 2436
2026
Q1 		– Sell
-2
Closed -$79 – 4030
2025
Q4 		$79 Hold
2
– – ﹤0.01% 3476
2025
Q3 		$71 Buy
+2
New +$69 ﹤0.01% 3613

Other funds holding ATRC

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return

SBI Securities's ATRC Position: Q3 2026 in Review

SBI Securities opened a new position in AtriCure (ATRC) in Q3 2026: 51 shares worth $2.87K. The stake represents ﹤0.01% of the portfolio and ranks #2436 among its holdings. This is a return to the name: SBI Securities previously reported a position in ATRC as recently as Q4 2025.

SBI Securities first reported a position in ATRC in Q3 2025 and has held it in 3 quarters since. 221 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • SBI Securities held 51 shares of AtriCure worth $2.87K as of Q3 2026.
  • AtriCure was a new SBI Securities position in Q3 2026.
  • AtriCure made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2436 holding.
  • SBI Securities first reported a position in AtriCure in Q3 2025 and has held it in 3 quarters since.
  • 221 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.